Bio-Rad Reports Third-Quarter 2023 Financial Results

26.10.2023 - Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostics products, today announced financial results for the third quarter ended September 30, 2023. Third-quarter 2023 total net sales were ...

Related Keywords

California ,United States ,China ,Norman Schwartz ,European Union In Vitro Diagnostics Regulation ,Exchange Commission ,Bio Rad Laboratories Inc ,Company Annual Report On Form ,Life Science ,Clinical Diagnostics ,Chief Executive ,Currency Neutral Reporting ,Bio Rad Laboratories ,Rad Laboratories ,Private Securities Litigation Reform Act ,Financial Condition ,Annual Report ,Quarterly Report ,Consolidated Statements ,European Union ,Vitro Diagnostics Regulation ,Bio Rad Laboratoriesa Chart ,Io Rad Laboratoriesa Kurs ,Io Rad Laboratoriesa Aktie ,